Helsingborg, Sweden

Torbjorn Stalhandske

This inventor holds 1 USPTO granted patent. Top assignee: Kabi Pharmacia Aktiebolag. Active years: 1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Torbjorn Stalhandske. Retrieved from https://idiyas.com/inventor/torbjorn-stalhandske

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1994

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Torbjorn Stalhandske: Innovator in Immunomodulating Compounds

Introduction

Torbjorn Stalhandske is a notable inventor based in Helsingborg, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with immunomodulating activity. His work has implications for various therapeutic applications.

Latest Patents

Stalhandske holds a patent for "Derivatives of quinoline-3-carboxanilide." This patent includes compounds characterized by the formula ##STR1##, where R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, and R.sup.7 can be hydrogen, hydroxy, or methoxy. The compounds are designed to have immunomodulating activity, which can be crucial in medical treatments.

Career Highlights

Throughout his career, Stalhandske has been associated with Kabi Pharmacia Aktiebolag, a company known for its focus on pharmaceutical innovations. His work has contributed to advancements in drug development and therapeutic solutions.

Collaborations

Stalhandske has collaborated with notable colleagues, including Per O Gunnarsson and Kerstin Strandgarden. These partnerships have fostered a collaborative environment that enhances research and development efforts.

Conclusion

Torbjorn Stalhandske is a distinguished inventor whose work in immunomodulating compounds has the potential to impact the pharmaceutical industry significantly. His contributions continue to pave the way for innovative therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…